MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comorbid Parkinson’s disease and Myasthenia Gravis: A Case-Control Study

K. Lafaver, D. Mohanty, C. Bodkin, M. Brown, A. Druker, J. Farmer, J. Fleisher, I. Gambhir, T. Harlow, F. Leon-Sarmiento, C. Perry, Z. Wang, A. Espay (Louisville, KY, USA)

Meeting: 2019 International Congress

Abstract Number: 944

Keywords: Dysphagia, Myasthenia gravis, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To evaluate the clinical features of patients with Parkinson’s Disease (PD) with versus without comorbid Myasthenia Gravis (MG).

Background: The recognition of the co-occurrence of myasthenia gravis (MG) in Parkinson’s Disease (PD) is challenging, given the symptomatic overlap.

Method: We designed a multi-center case-control study selecting patients with a diagnosis of PD based on UK brain bank criteria and MG based on clinical, electrophysiological and immunological features (PD-MG) as cases and age- and gender-matched PD-only patients as controls. We evaluated demographics, family history, motor and non-motor symptoms, laboratory and electrophysiological data, and medication use. PD severity was assessed by Hoehn and Yahr stage and UPDRS motor scores.

Results: 14 PD-MG cases (79% males, 21% females; mean age 72.5 +/-8.4 years) were compared to 14 PD-only controls. Duration of PD symptoms, time to diagnosis, disease stage, and daily levodopa equivalent dose were similar in cases and controls. Tremor was the predominant presenting phenotype in both groups. Dysphagia was more frequently reported in PD-MG than PD-only patients (p=0.04). PD-MG cases included 8 with generalized MG, 4 ocular, 1 bulbar and 1 combined. PD diagnosis predated MG in 35.7% whereas MG predated PD in 42.9% of cases; with 21.3% being diagnosed concurrently. MG diagnosis was confirmed by positive acetylcholine receptor antibodies (n=8) and electrophysiologic testing (n=8).  MG was under treatment in all PD-MG cases; PD in all but two patients in both groups. Two PD-MG cases required ICU admission and intubation for respiratory failure.

Conclusion: Comorbid MG in PD has rarely been described in the literature. Olfactory dysfunction, sleep disorders, and dysphagia can occur in PD and MG. While there were no differences in initial symptom presentation in PD-MG versus PD alone, dysphagia was more common in the PD-MG group. Dysphagia alone or with ptosis (“apraxia of eyelid opening”) or diplopia may represent clues for suspecting comorbid MG in patients with PD.

To cite this abstract in AMA style:

K. Lafaver, D. Mohanty, C. Bodkin, M. Brown, A. Druker, J. Farmer, J. Fleisher, I. Gambhir, T. Harlow, F. Leon-Sarmiento, C. Perry, Z. Wang, A. Espay. Comorbid Parkinson’s disease and Myasthenia Gravis: A Case-Control Study [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/comorbid-parkinsons-disease-and-myasthenia-gravis-a-case-control-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/comorbid-parkinsons-disease-and-myasthenia-gravis-a-case-control-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley